Investor Relations

Pfenex is a development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology to develop and improve protein therapies.  Pfenex has developed a diversified pipeline consisting of multiple assets, including approved, next generation and novel therapeutics.

Price Data
NYSE AmericanPFNX

Pfenex is a development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology to develop and improve protein therapies.  Pfenex has developed an advanced pipeline of potential therapeutic equivalents, vaccines, and biologics.

Upcoming Events
Tuesday, June 9, 2020
7:20am EDT

View All

Investor Resources
Corporate Presentation
Annual Report
SEC Filings
Corporate Governance
Subscribe to our Investor Alerts
* Required Fields